Condition

Type 1 Diabetes

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 1,205 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1,205

Recruiting121

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 DiabetesNCT07864168 · 2026-10-01

C-Carbs: A CGM-guided Approach to Teaching Carb AwarenessNCT07807280 · 2026-09-30

Telehealth Music Therapy for Adults With Endocrine Disorder and DepressionNCT07413874 · 2026-07-16

NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational DiabetesNCT07560813 · 2026-07-06

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1DNCT07593625 · 2026-05-25

Simultaneous Measurement and Responsive Treatment - Part 2NCT07655076 · 2026-05-19

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarNCT07284511 · 2026-05-19

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry StudyNCT07676565 · 2026-03-24

Long-Term Outcomes of Teplizumab in Routine Clinical CareNCT07360080 · 2026-03-19

Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)NCT07317102 · 2026-03-16

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)NCT07457580 · 2026-03-16

Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert OpinionsNCT07498738 · 2026-03-13

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesNCT07061574 · 2026-03-10

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)NCT07293715 · 2026-02-25

Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesNCT07573228 · 2026-02-23

A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500NCT07341373 · 2026-02-10

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.NCT07287943 · 2026-02-09

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes MellitusNCT07258394 · 2026-01-27

Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)NCT07038473 · 2025-12-17

EmoTIChealth: Promoting Adolescent Health Through a Serious Game.NCT07212530 · 2025-12-01

The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade InflammationNCT07247734 · 2025-12-01

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesNCT07187531 · 2025-11-25

Discovery DiabetesNCT07116434 · 2025-11-14

Precision Administration of Anti-thymocyte Globulin With or Without VerapamilNCT06455319 · 2025-11-12

Early Detection of Type 1 DiabetesNCT06984185 · 2025-11-05

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United StatesNCT07260110 · 2025-10-31

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic ConditionsNCT07638345 · 2025-10-30

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesNCT06976619 · 2025-10-03

Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin MonitoringNCT07254364 · 2025-09-11

T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 DiabetesNCT07059806 · 2025-09-05

Home-based Oral Glucose Tolerance Test for Type 1 Diabetes ScreeningNCT07155252 · 2025-08-26

Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2NCT07097818 · 2025-08-18

A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving VerapamilNCT07199946 · 2025-08-06

Type 1 Diabetes Adolescents for Healthier Lifestyles StudyNCT06878872 · 2025-08-01

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusNCT06575426 · 2025-06-10

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)NCT06783309 · 2025-05-12

A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 DiabetesNCT06752928 · 2025-05-12

Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin InjectionsNCT06966427 · 2025-05-08

Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control IndividualsNCT06427421 · 2025-05-06

Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes MellitusNCT07150052 · 2025-05-01

Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 DiabetesNCT06951074 · 2025-04-01

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantNCT06832410 · 2025-03-31

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic ControlNCT06875167 · 2025-03-17

Intensive Dietary and Activity Counselling (IDAC)NCT06670625 · 2025-03-15

Commercial or Open Source Closed Loop Impact on Pregnancy StudyNCT06654713 · 2025-03-13

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 DiabetesNCT07564752 · 2025-02-25

Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 DiabetesNCT06683391 · 2025-02-06

Association Between Sarcopenia And Diabetic Neuropathy In Adults With Type 1 Diabetes, A Pilot StudyNCT06902597 · 2025-02-01

Type 1 Diabetes, Exercise and Mentoring TrialNCT06296992 · 2025-02-01

Glycemic Control and Osteohealth in Adults Living With Type 1 DiabetesNCT06158503 · 2025-02-01

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 DiabetesNCT06435156 · 2025-01-28

Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 DiabetesNCT06803446 · 2024-12-18

A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D PatientsNCT06665815 · 2024-12-15

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous SemaglutideNCT06387199 · 2024-12-01

Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop SystemsNCT06575790 · 2024-11-25

Closed Loop Context Aware AIDNCT06676657 · 2024-11-22

The Effect Of Model-Based Dıgıtal Game On Metabolıc Control, Self-Effıcıency And Qualıty Of Lıfe In Chıldren Wıth Type 1 DıabetesNCT05923632 · 2024-11-20

Registry for Stage 2 Type 1 DiabetesNCT06481904 · 2024-09-27

Sleep Coach for Adolescents With Type 1 DiabetesNCT06516614 · 2024-09-18

Family Intervention for Black Teens With Type 1 DiabetesNCT06275412 · 2024-09-16

Common interventions

Leading sponsors

Medtronic MiniMed, Inc.32 Institut de Recherches Cliniques de Montreal31 Rabin Medical Center30 University of Colorado, Denver30 Yale University24 Steno Diabetes Center Copenhagen22 University of Cambridge17 Jaeb Center for Health Research16 Massachusetts General Hospital15 University of Virginia15 Assistance Publique - Hôpitaux de Paris13 University of Alberta13 Joslin Diabetes Center12 Medical University of Graz12 Oregon Health and Science University12

Trial status mix

COMPLETED752

UNKNOWN129

RECRUITING121

TERMINATED56

WITHDRAWN48

ACTIVE_NOT_RECRUITING47

NOT_YET_RECRUITING37

ENROLLING_BY_INVITATION7

SUSPENDED7

NO_LONGER_AVAILABLE1

Phase mix

NA584

PHASE2162

PHASE1110

PHASE375

PHASE453

EARLY_PHASE125

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.